The Efficacy and safety evaluation of Susu Xiao'er Zhike Granules in the treatment of the cough caused by the common cold(wind cold cough syndromes) in children: a randomized, double-b

The First Teaching Hospital of Tianjin University of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Diagnosed as common cold standard, and VAS score of daytime or night-time cough >= 40mm;
•2. Diagnosed as wind cold cough syndrome;
•3. Aged 6-14 ( < 14) years;
•4. The course of cough is <= 48 hours;
•5. The maximum temperature is <= 38 degree C within 24 hours before visit;
•6. The informed consent process complies with the requirement,and the legal representative and the child (>= 8 years old) sign the informed consent form.

•1. Accompanied by sore throat, obvious fever;
•2. The WBC, NEU and CRP all exceeded 1.2 times of the upper limit of the reference value, and the researchers considered bacterial infection;
•3. With complication, such as otitis media, sinusitis, acute bronchitis, pneumonia;
•4. Acute bronchitis, pneumonia have been cured less than 8 weeks;
•5. With a medical history of seasonal or perennial allergic rhinitis, chronic sinusitis, chronic otitis media, bronchial asthma, chronic cough or recurrent respiratory tract infection;
•6. Patients with severe malnutrition;
•7. Patients with other serious systemic diseases of the cardiovascular, brain, liver, kidney and hematopoietic systems, any anatomical or respiratory abnormalities or mental disorders;
•8. Allergic to the experimental drugs;
•9. Received antihistamines or any cough medicine, oral or inhaled steroid preparation before enrollment;
•10. The investigator considers it inappropriate to participate in this clinical trial.

发起方

The First Teaching Hospital of Tianjin University of TCM